Intellectual Property Valuation: The 2026 Complete Checklist

Professional office at golden hour with intellectual property valuation due diligence documents

Quick Answer

Intellectual property (IP) valuation covers patents, trademarks, copyrights, trade secrets, and other intangible assets. The three standard approaches recognized by WIPO (World Intellectual Property Organization), AICPA, and FASB are: (1) Cost Approach — historical cost or replacement cost to recreate the IP; (2) Market Approach — comparable IP transactions (royalty rates, license fees); (3) Income Approachdiscounted cash flow from incremental income attributable to the IP. The Income Approach is generally preferred for active commercial IP, with the Relief from Royalty method being the most common implementation. Common use cases: M&A (IRC Section 1060 + GAAP business combinations under ASC 805), licensing negotiations, litigation damages, transfer pricing, financial reporting (FASB ASC 350 goodwill impairment). For M&A asset purchase transactions, IP valuation drives the buyer’s tax-basis step-up and amortization schedule over 15 years (IRC Section 197).

Intellectual property valuation is one of the most complex disciplines in business valuation due to the inherent intangibility of the asset, the difficulty of identifying directly comparable transactions, and the wide variation in IP value drivers across patent types, trademark portfolios, and trade secret categories. The discipline is governed by WIPO standards, AICPA SSVS-1, FASB ASC 805 (business combinations) and ASC 350 (intangible asset impairment), and the OECD Transfer Pricing Guidelines for cross-border situations.

This guide covers the three standard IP valuation approaches (Cost, Market, Income), the major methods within each (Relief from Royalty, Excess Earnings, Multi-Period Excess Earnings Method, Greenfield, With/Without), the major use cases (M&A asset allocation, licensing, litigation damages, transfer pricing, financial reporting), and the specific challenges of valuing patents, trademarks, copyrights, and trade secrets.

CT Acquisitions runs sell-side M&A processes for founder-owned U.S. businesses. For technology-enabled services, biotech, SaaS, specialty manufacturing, and brand-driven consumer businesses, IP often represents a substantial portion of enterprise value. IP valuation is integral to defensible deal structuring.

TL;DR

  • 3 standard approaches: Cost (historical/replacement), Market (comparable license rates), Income (DCF of incremental income from IP).
  • Income Approach methods: Relief from Royalty (most common), Excess Earnings, Multi-Period Excess Earnings Method (MPEEM), Greenfield, With/Without.
  • IP categories: patents, trademarks, copyrights, trade secrets, customer relationships, contractual rights, brand/goodwill.
  • Use cases: M&A (ASC 805 business combinations + IRC Section 1060), licensing, litigation damages, transfer pricing, financial reporting (ASC 350 impairment).
  • M&A asset allocation: IP values drive buyer’s tax-basis step-up + 15-year amortization per IRC Section 197.
  • Patent valuation: technology category, geographic scope, remaining patent life (typically 20 years from filing), claim breadth, infringement enforcement track record.
  • Trademark valuation: brand recognition, geographic scope, registration jurisdictions, descriptive vs arbitrary, similar mark coexistence.
  • Trade secret valuation: most difficult; depends on competitive advantage period, secrecy maintenance, defensibility.
  • Standards: WIPO IP valuation guidelines, AICPA SSVS-1, FASB ASC 805/350, OECD Transfer Pricing Guidelines.
  • Credentials: ASA-BV (Business Valuation), CVA (Certified Valuation Analyst, NACVA), CLP (Certified Licensing Professional).

The 3 Standard IP Valuation Approaches

1. Cost Approach

Values IP based on the cost to create or replace it:

  • Historical Cost: Actual development costs incurred (R&D, legal, filing fees). Limited usefulness — historical cost rarely matches market value.
  • Replacement Cost: Estimated cost to recreate IP with equivalent functionality today. More useful but doesn’t capture market-acceptance value.
  • Reproduction Cost: Estimated cost to create exact replica.

Best for: Early-stage IP with no commercial track record. Limited usefulness for established commercial IP.

2. Market Approach

Values IP based on comparable transactions in the marketplace:

  • Comparable license transactions: Royalty rates from similar IP licenses. Sources: ktMINE (CFRA), RoyaltySource, RoyaltyStat.
  • Comparable IP sales: Patent and trademark sale prices. Sources: USPTO Patent Sales records, M&A databases.

Best for: Commercially active IP with reasonable comparable transactions available. Most useful for trademarks and pharmaceutical patents (where licensing comparables are robust).

3. Income Approach (most common for commercial IP)

Values IP based on incremental income attributable to the IP, discounted to present value. Multiple sub-methods:

Relief from Royalty (most common)

Hypothesizes the IP owner doesn’t own the IP and must license it. Royalty saved by ownership = value. Steps: project revenue subject to IP × hypothetical royalty rate × (1 – tax rate), discount at WACC + risk premium.

Excess Earnings / Multi-Period Excess Earnings Method (MPEEM)

Income attributable to IP = total earnings – returns to other assets (working capital, fixed assets, other intangibles). Allocates “excess” earnings to the IP being valued. Most common for customer relationships, contractual rights.

Greenfield Method

Models hypothetical startup that uses the IP. Valuation = NPV of after-tax cash flows. Useful for early-stage technology IP.

With and Without Method

Values business with the IP vs without. Difference = IP value. Useful when the IP can be clearly separated from the rest of the business.

IP Categories + Use Cases

Patent Valuation

Key drivers:

  • Technology category (pharmaceutical > software > mechanical, generally).
  • Remaining patent life (20 years from filing, less for design/utility variations).
  • Claim breadth: broader claims = more value (but more vulnerable to invalidation).
  • Geographic scope (US + EU + Japan + China typical premium portfolio).
  • Forward citations: patents cited by later patents indicate technological influence.
  • Infringement enforcement track record: established enforcement = higher value.
  • Substitutability: design-around difficulty.

Trademark Valuation

Key drivers:

  • Brand recognition: consumer awareness, market share.
  • Registration scope: jurisdictions, classes registered.
  • Descriptive vs arbitrary: arbitrary marks (e.g., “Apple” for computers) are stronger than descriptive.
  • Coexistence with similar marks: weaker if confusingly similar marks exist.
  • Use history: continuous commercial use.
  • Premium pricing power: brand premium customers will pay.

Trade Secret Valuation

Most difficult to value. Key drivers:

  • Competitive advantage period: how long can the secret be maintained?
  • Secrecy maintenance: documented protection measures (employee agreements, access controls).
  • Defensibility: legal protections under DTSA (Defend Trade Secrets Act).
  • Independent development risk: probability competitor develops independently.

Major Use Cases

  • M&A asset allocation: ASC 805 business combinations + IRC Section 1060. IP values drive buyer’s tax-basis step-up + 15-year Section 197 amortization.
  • Licensing negotiations: defensible royalty rate for in-licensing or out-licensing.
  • Litigation damages: patent infringement (reasonable royalty or lost profits), trademark infringement, trade secret misappropriation.
  • Transfer pricing: cross-border IP transfers under IRC Section 482 + OECD Guidelines.
  • Financial reporting: ASC 350 goodwill impairment testing, ASC 805 purchase price allocation.

M&A Asset Allocation + Standards

IRC Section 1060 + ASC 805 Asset Allocation

Asset purchase transactions require allocation of purchase price across asset classes per IRC Section 1060 (tax) and ASC 805 (financial reporting). The asset classes:

  1. Cash and cash equivalents
  2. Actively traded personal property (Class II)
  3. Accounts receivable (Class III)
  4. Inventory (Class IV)
  5. All other assets except intangibles, going concern, goodwill (Class V) — including M&E
  6. Section 197 intangibles other than goodwill and going concern value (Class VI) — patents, trademarks, copyrights, customer relationships, contractual rights
  7. Goodwill and going concern value (Class VII)

Tax-Basis Step-Up Implications

  • Section 197 intangibles (Class VI): amortized over 15 years, straight-line. Includes patents, trademarks, copyrights, customer relationships.
  • Buyer benefits from amortization of allocated IP value over 15 years (deductible against operating income).
  • Seller pays ordinary income on portion allocated to depreciation recapture, capital gains on portion allocated to capital assets.

Standards and Credentials

  • WIPO IP Valuation Guidelines: International standard.
  • AICPA SSVS-1: Standards for CPAs performing valuations.
  • FASB ASC 805: Business combinations (purchase price allocation).
  • FASB ASC 350: Goodwill and intangible asset impairment.
  • OECD Transfer Pricing Guidelines: Cross-border IP transfers.
  • USPAP: Uniform Standards of Professional Appraisal Practice (general).

Common credentials: ASA-BV (Accredited Senior Appraiser, Business Valuation), CVA (Certified Valuation Analyst, NACVA), CLP (Certified Licensing Professional, LES). For complex litigation damages, often a Ph.D. economist or finance professor with court-recognized expertise.

Frequently Asked Questions: Intellectual property valuation due diligence

What is intellectual property valuation?

A specialty discipline within business valuation focused on the value of patents, trademarks, copyrights, trade secrets, and other intangible assets. Governed by WIPO standards, AICPA SSVS-1, FASB ASC 805/350, and OECD Transfer Pricing Guidelines.

What are the 3 standard IP valuation approaches?

Cost Approach (historical or replacement cost), Market Approach (comparable license rates and IP sales), Income Approach (DCF of incremental income from IP). Income Approach is generally preferred for commercial IP.

What is the Relief from Royalty method?

Most common IP valuation method. Hypothesizes the owner doesn’t own the IP and must license it. Royalty saved by ownership = IP value. Steps: project revenue subject to IP × hypothetical royalty rate × (1 – tax rate), discount at WACC + risk premium.

What is the most common use case for IP valuation?

M&A asset allocation under ASC 805 (financial reporting) and IRC Section 1060 (tax). IP values determine buyer’s tax-basis step-up and 15-year amortization schedule under IRC Section 197.

How long are IP assets amortized for tax purposes?

15 years straight-line per IRC Section 197. Includes patents, trademarks, copyrights, customer relationships, contractual rights. Buyer benefits from annual amortization deduction against operating income.

What credentials do IP valuators have?

ASA-BV (Accredited Senior Appraiser, Business Valuation), CVA (Certified Valuation Analyst, NACVA), CLP (Certified Licensing Professional, LES). For litigation damages, often Ph.D. economists or finance professors with court-recognized expertise.

What drives patent value?

Technology category (pharma > software > mechanical generally), remaining patent life (20 years from filing), claim breadth, geographic scope, forward citations, infringement enforcement track record, substitutability difficulty.

What drives trademark value?

Brand recognition, registration scope (jurisdictions, classes), descriptive vs arbitrary (arbitrary stronger), coexistence with similar marks, use history, premium pricing power.

Why is trade secret valuation difficult?

Trade secret value depends on competitive advantage period, secrecy maintenance, defensibility under DTSA (Defend Trade Secrets Act), and independent development risk. Unlike patents and trademarks with public records, trade secrets have minimal external comparables.

Does CT Acquisitions work with IP-heavy businesses?

Yes. For technology-enabled services, biotech, SaaS, specialty manufacturing, and brand-driven consumer businesses, IP often represents substantial enterprise value. We integrate IP valuation into our sell-side process. Buyer-paid model: seller pays nothing.

Christoph Totter, Founder of CT Acquisitions

About the Author

Christoph Totter is the founder of CT Acquisitions, a buyer-paid M&A advisor headquartered in Sheridan, Wyoming. We run sell-side M&A processes for founder-owned U.S. businesses ($1M-$25M EBITDA). The buyer pays our fee at closing — the seller pays nothing. Connect on LinkedIn · Get in touch

Buying or selling? Run institutional-grade diligence with CT.

CT Acquisitions is a buyer-paid M&A advisor. The seller pays nothing — the buyer pays the success fee at closing.

Schedule a Confidential Call